Maccura Biotechnology Co.Ltd
SHZ: 300463.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Wu Mingjian
- Employees
- 3,362
- Headquarters
- Chengdu, China
- IPO year
- 2015
- Market cap
- CN¥6.5B
- Website
- https://www.maccura.com
Loading 300463…
Loading profile data…Frequently asked questions about 300463
What does Maccura Biotechnology Co.Ltd (300463.SZ) do?
Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of IVD products and related services in China and internationally. The company offers immunoassay products, such as chemiluminescence analyzers and reagents; clinical chemistry reagents for hepatic function, glycometabolism, iron and other, renal function, c...
Where does 300463.SZ trade?
Maccura Biotechnology Co.Ltd (300463.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300463.SZ in?
Maccura Biotechnology Co.Ltd (300463.SZ) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Maccura Biotechnology Co.Ltd?
Wu Mingjian is the chief executive officer of Maccura Biotechnology Co.Ltd (300463.SZ).
Where is Maccura Biotechnology Co.Ltd headquartered?
Maccura Biotechnology Co.Ltd is headquartered in China.
Does 300463.SZ pay a dividend?
Yes — Maccura Biotechnology Co.Ltd (300463.SZ) paid a trailing twelve-month dividend of CNY 0.10 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300463.SZ go public?
Maccura Biotechnology Co.Ltd (300463.SZ) completed its initial public offering in 2015.